Principal AIM:
- To develop and validate outcome measures of childhood uveitis associated to Juvenile Idiopathic Arthritis
- Forster prospective clinical trials in childhood uveitis associated to Juvenile Idiopathic Arthritis
Currently running project:
To validate the Outcome meausures to assess the proposed composed Score for Response, Inactivity, Remission and Damage in a prospective multicenter study for uveitis associated to Juvenile Idiopathic Arthritis .
Methods
We include patients in the validation of the Response, Inactivity, Remission and Damage, who start a second line biologic or a nonbilogic disease modifying agent. IRB is pending.
- For data input, we use the online database
- The patient data is pseudomized
- Planned first patient in April 2017
- Planned Recruitment period 12 months – till April 2018